FindTrial
Sign In

Palliative treatment of carcinoma esophagous with an Indian made stent

Assessment of efficacy of indigineously manufactured self expandable metal stent for palliation of carcinoma esophagous

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/04/003603
Enrollment
20
Registered
2013-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Advanced unresectable cancer

Interventions

Intervention1: Esophageal stent: Indigineously developed self expanding metal stent will be placed in patients with inoperable esophageal cancer Control Intervention1: Comparator: No comparator arm is

Sponsors

Mitra Industries Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)Locally advanced unresectable cancer (invasion of tracheobronchial tree, aorta, pulmonary vasculature) b)Metastatic disease c)Poor performance status (Eastern cooperative oncology group performance status (3,4)

Exclusion criteria

Exclusion criteria: a)Not willing to give consent b)Previous history of stent placement

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of an indigenously developed self-expandable metal stent for relief of dysphagia in patients with inoperable esophageal cancerTimepoint: 1,3 , 6 and 12 months—

Secondary

MeasureTime frame
1) Stent complicationsTimepoint: 1, 3, 6 , 9 and 12 months—

Countries

India

Contacts

Public ContactDr Pramod Garg

AIIMS, New Delhi

pgarg10@gmail.com011-26593556

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026